| BJI | bone and joint infection |
| CLSI | Clinical and Laboratory Standards Institute |
| CNS | central nervous system |
| CRAB | carbapenem-resistant Acinetobacter baumannii |
| ESBL | extended-spectrum β-lactamase |
| ESC | European Society of Cardiology |
| EUCAST | European Committee on Antimicrobial Susceptibility Testing |
| ICTRP | International Clinical Trials Registry Portal |
| KPC | Klebsiella pneumoniae carbapenemase |
| MBL | metallo-β-lactamase |
| MDR | multidrug resistant |
| MIC | minimal inhibitory concentration |
| MRSA | methicillin-resistant Staphylococcus aureus |
| MSSA | methicillin-susceptible Staphylococcus aureus |
| MurA | UDP-N-acetylglucosamine enolpyruvyl transferase |
| PD | pharmacodynamic |
| PDR | pandrug-resistant |
| PK | pharmacokinetic |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RCT | randomized controlled trial |
| RoB 2 | Cochrane risk-of-bias tool for randomized trials |
| Robvis | risk-of-bias visualization |
| ROBINS-I V2 | Risk Of Bias In Non-randomized Studies–of Interventions, Version 2 |
| SOC | standard of care |
| SOFA | sequential organ failure assessment |
| UTI | urinary tract infection |
| VAP | ventilator-associated pneumonia |
| WHO | World Health Organization |
| XDR | extensively drug-resistant |